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Objectives: Regulation of lipopolysaccharide (LPS) chemical composition, particularly its 
lipid A domain, is an important, naturally occurring mechanism that drives bacteria-host 
immune system interactions into either a symbiotic or pathogenic relationship. Members of the 
subgingival oral microbiota can critically modulate host immuno-inflammatory responses by 
synthesizing different LPS isoforms. The objectives of this study were to analyse subgingival 
lipid A profiles and endotoxin activities in periodontal health and disease and to evaluate the 
use of the recombinant factor C assay as a new, lipid A-based biosensor for personalized, point-
of-care periodontal therapy. 
Materials and Methods: Subgingival plaque samples were collected from healthy individuals 
and chronic periodontitis patients before and after periodontal therapy. Chemical composition 
of subgingival lipid A moieties was determined by ESI-Mass Spectrometry. Endotoxin activity 
of subgingival LPS extracts was assessed using the recombinant factor C assay, and their 
inflammatory potential was examined in THP-1-derived macrophages by measuring TNF-α 
and IL-8 production.  
Results: Characteristic lipid A molecular signatures, corresponding to over-acylated, bi-
phosphorylated lipid A isoforms, were observed in diseased samples. Healthy and post-
treatment samples were characterized by lower m/z peaks, related to under-acylated, hypo-
phosphorylated lipid A structures. Endotoxin activity levels and inflammatory potentials of 
subgingival LPS extracts from periodontitis patients were significantly higher compared to 
healthy and post-treatment samples. 
Conclusions: This is the first study to consider structure-function-clinical implications of 
different lipid A isoforms present in the subgingival niche and sheds new light on molecular 
pathogenic mechanisms of subgingival biofilm communities.  
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Clinical Relevance: Subgingival endotoxin activity (determined by lipid A chemical 
composition) could be a reliable, bacterially-derived biomarker and a risk assessment tool for 





















Personalised healthcare is beginning to achieve its goal of delivering the right therapy to the 
right patient at the right time. The wave of predictive, preventive and personalised medicine is 
rapidly influencing decisions made with regard to prevention, early diagnosis and treatment of 
oral diseases [1]. Chronic periodontitis is an irreversible, multifactorial, inflammatory disease 
of the tissues supporting the teeth and is caused by a disruption to normal homeostatic 
mechanisms by numerous bacterial species found in subgingival dental plaque [2].  
The causative basis for chronic periodontitis relates to an excessive host innate immune 
response to a unique bacterial consortium and the virulence factors produced by certain 
pathogenic members of the subgingival biofilm community [3]. Lipopolysaccharide (LPS) is a 
key microbial stimulus that triggers the host response in periodontal tissues [4]. LPS is the 
major constituent of the outer membrane of Gram-negative bacteria where it plays an important 
structural role and mediates interaction between bacteria and the environment [5]. LPS is 
composed of hydrophilic O-antigen polysaccharides and an amphipathic lipid A anchor which 
is incorporated into the outer bacterial cell membrane. Lipid A, the bioactive centre of LPS, is 
considered to be an archetypal microbe-associated molecular pattern (MAMP) molecule [6]. 
Multicellular organisms, from horseshoe crabs and fruit flies to humans, have evolved proteins 
specialized for the recognition of LPS. In horseshoe crabs, Factor C is an effective biosensor, 
which alerts the horseshoe crab to the presence of a Gram-negative invader, while in humans, 
phagocytic cells recognize non-self motifs through an extensive repertoire of evolutionary 
conserved Toll-like Receptors (TLRs) [7]. Activation of TLRs by lipid A in macrophages 
triggers intracellular signalling cascades that lead to secretion of chemokines and pro-
inflammatory cytokines responsible for the development of clinical signs of inflammation and, 
in the case of periodontitis, alveolar bone loss [8].  
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TLRs and Factor C can be activated by structurally diverse lipid A molecules. Minor changes 
in the chemical composition of lipid A can affect LPS’s inflammatory potential. The potency 
of TLR activation decreases in line with a decrease in the number of fatty acids and phosphate 
groups attached to the lipid A diglucosamine backbone [9]. The subgingival biofilm 
community has the potential to modulate TLR activity and subsequently subvert intricate 
homeostatic mechanisms involved in the maintenance of periodontal health, by the expression 
of different LPS isoforms [10]. Tetra- and penta-acylated lipid A structures of Porphyromonas 
gingivalis LPS have been shown to differentially activate TLR4-mediated NF-κB signaling 
pathway in human gingival fibroblasts and critically modulate the expression of pro-
inflammatory cytokines [11]. 
The elucidation of this pathogenic mechanism in relation to lipid A structure-function-clinical 
implications is central to the understanding of host-microbial interaction at periodontally 
healthy and diseased sites. Therefore, in this study we examined structural diversity of 
subgingival lipid A isoforms in healthy and diseased patients (before and after periodontal 
therapy) and evaluated the Factor C based assay and its interaction with subgingival LPS 
extracts as a bacterially derived biomarker for prevention, early intervention and patient-
centred management of chronic periodontitis. 
 
MATERIALS AND METHODS 
Study population 
Approval of the study protocol was obtained from the Health Research Authority, UK (NRES 
Committee South West - Cornwall and Plymouth 14/SW/0020) and the study was conducted 
in accordance with the Helsinki Declaration of 1975, as revised in 2013. All participants 
provided written consent. Thirty-two individuals (11 female, 21 male, mean age 46) with 
chronic periodontitis (CP) and 33 systemically and periodontally healthy (H) persons (18 
6 
female, 15 male, mean age 31) were recruited from patients presenting to the Peninsula Dental 
School, University of Plymouth, UK. 
CP patients were diagnosed in accordance to the accepted clinical criteria [12]: a minimum of 
4 teeth in each jaw with a probing depth (PD) of ≥ 5 mm; bleeding on probing and clinical 
attachment level (CAL) of ≥ 4 mm; with ≥ 50% alveolar bone loss in at least two quadrants 
(assessed radiographically). Periodontal health was defined as ≥ 90% of the measured sites 
with PD < 3 mm and no bleeding on probing (BOP). Clinical parameters (six-point pocket 
chart, plaque index (PI) and bleeding index (BI)) and demographic characteristics of the study 
population were recorded as well as their smoking status (3 smokers in the healthy group and 
14 in CP) (Table 1.). Patients with medical disorders unrelated to periodontal disease, but likely 
to influence study outcomes, or with antibiotic or periodontal treatment in the previous 6 
months were excluded from the study.  
Insert Table 1. 
  
Subgingival biofilm collection 
Subgingival biofilm samples were collected by inserting sterile paper points for 30 seconds in 
three deepest bleeding pockets in CP patients and in healthy patients from three non-bleeding 
sites (mid-labial of UR1, mesio-buccal of UR6 and mesio-buccal of LL6) and were pooled for 
each individual patient. Diseased patients underwent conventional, non-surgical periodontal 
therapy and subgingival biofilm samples were collected from the same sites, three months after 
the completion of the therapy. 
LPS extraction and lipid A isolation 
LPS from subgingival samples was extracted using the LPS extraction kit (iNtRON 
Biotechnology, S.Korea) following the manufacturer’s instructions. Extracted LPS was re-
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suspended in 500µl of LPS-free water and stored at 4oC. For lipid A isolation, all healthy, 
diseased and post-treatment samples were pooled and lipid A was isolated by mild hydrolysis 
as described by Coats et al. [13]. 
Mass-spectrometry  
Lipid A was desalted with 0.1M ammonium citrate and dissolved in methanol/dichloromethane 
(3:1, v/v). Mass spectrometric analysis of lipid A was performed on a 6530 Accurate Mass 
Quadrupole Time-Of-Flight (Q-TOF) MS system (Agilent Technologies, Singapore). Positive 
and negative ion mass spectra were recorded over the range of 1000–2100 m/z. The 
electrospray ion source (ESI) was operated using the following conditions: pressure of 
nebulizing gas (N2) was 30 psi; temperature and flow rate of drying gas (N2) were 300°C and 
7 L/min, respectively; temperature and flow rate of sheath gas were 300°C and 11 L/min, 
respectively. The capillary voltage was set to 3.5 kV, the nozzle voltage to 2 kV, the fragmentor 
potential to 100 V and the skimmer potential to 65 V. 
Endotoxin activity (Factor C assay) 
The Limulus amebocyte lysate (LAL) alternative, recombinant Factor C assay (rFC), is a 
representative of modern recombinant methods, moving away from the animal source, which 
for decades has been the horseshoe crab. The endotoxin-specificity of the Factor C assay 
eliminates all false-positive and elevated results seen by ß-glucan reactions in the LAL test. 
Subgingival LPS extracts were diluted 1:10 in endotoxin free water and endotoxin activity was 
measured according to manufacturer’s instructions (EndoZyme, Hyglos, Germany). 
Inflammatory potential of subgingival LPS isolates 
For THP-1 differentiation into macrophages, the cells were plated at a density of 1×106 cell/ml 
in complete RPMI medium (Lonza, UK) and differentiated with PMA (25 ng/ml) for 3 days 
followed by 24h resting in fresh medium [14]. 
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Cells were stimulated with 50 µl of subgingival LPS extracts per ml of cells for 18 hours. Cell 
free supernatants were collected and concentrations of IL-8 and TNF-α were measured by 
ELISA (BD Bioscience, UK). 
Statistical Analyses 
All samples, participants and clinical data were anonymised and locked before the codes were 
revealed. In order to analyse differences between examined groups of patients, one-way 
analysis of variance with Tukey post-hoc test was performed, using GraphPad Software, San 
Diego, CA. Correlations between clinical parameters and LPS endotoxin activity and 
inflammatory potential were analysed using the Pearson correlation coefficient. A p value 
below 0.05 was considered significant (*<0.05; **<0.01; ***<0.001). All experiments were 
performed at least three times in duplicates.  
 
RESULTS 
Structural characterization of subgingival lipid A isoforms 
Characteristic lipid A molecular signatures were observed in the spectra of LPS extracts from 
the three groups of patients. Mass-spectrometry analyses of lipid A isolated from pooled 
healthy (H) and chronic periodontitis (CP) subgingival plaque samples revealed the presence 
of prominent, high m/z peaks (m/z between 1600-1900) in diseased samples, which were not 
present in the healthy group (Fig. 1(b) and 1(c)). These high m/z values are consistent with 
more phosphorylated and over-acylated lipid A isoforms as it is the case with reported 
P.gingivalis LPS (Fig. 1(a)). Interestingly, in subgingival samples taken from the same sites, 
three months after the completion of periodontal therapy, these ions were not detectable (Fig. 
1(d)) and the lipid A mass spectrum of the pooled post-treatment samples resembled the 
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spectrum of healthy individuals (especially in the positive-ion mode), consistent with less-
acylated, hypo-phosphorylated lipid A isoforms . 
 
Endotoxin activity of subgingival biofilm samples  
Endotoxin activity of subgingival LPS extracts was measured for each individual patient using 
the recombinant factor C assay. LPS extracts from chronic periodontitis patients showed 
significantly higher levels of endotoxin activity compared to healthy individuals (Fig. 2). Most 
healthy patients’ endotoxin activity was below the level of 10 EU while in a significant number 
of diseased patients (19) this value exceeded 20 EU. Smoking status did not appear to 
significantly influence the level of subgingival endotoxin activity, but there was a trend of 
lower values in diseased smokers (data not shown). Endotoxin activity of samples taken after 
periodontal treatment was significantly lower compared to the corresponding CP samples, with 
values at a similar range as for healthy individuals. Interestingly, in all three groups of samples 
there were two distinct sub-groups; one in the lower range of EU where most of the healthy 
and post-treatment samples were aggregated and one within a higher range of endotoxin 
activity where most of the CP samples congregated. These two sub-groups may represent 
differences in disease activity and progression, two of the disease signatures currently 
unmeasurable at point-of-care. 
The diagnostic performance of subgingival endotoxin activity as a biomarker for disease status 
was evaluated using the receiver operating curve (ROC) which demonstrated a good 
predictable value of endotoxin activity levels (area under the curve (AUC) of 0.94) and the 




Inflammatory potential of subgingival LPS extracts 
Inflammatory potential of subgingival LPS extracts from each patient was assessed in 
macrophages derived from THP-1 cells, by measuring the production of TNF-α and IL-8. The 
cytokine values were also correlated with corresponding endotoxin activity levels. TNF-α 
production by macrophages challenged with LPS extracts from most of the healthy individuals 
was undetectable while LPS extracts from diseased patients triggered significantly higher 
production of TNF-α (p<0.001) (Fig. 4(a)).  There was a trend of decreased TNF-α production 
by macrophages challenged with post-treatment LPS extracts. Similarly, IL-8 production was 
significantly greater in macrophages treated with diseased LPS extracts compared to both 
healthy and post-treatment samples (Fig. 4(b)). In addition, diseased samples triggered a wider 
range of TNF-α and IL-8 levels compared to healthy and post-treatment samples. Moreover, 
significantly higher levels of IL-8 than TNF-α were observed in the healthy group, depicting 
the importance of leukocytes transmigration for periodontal homeostasis. 
There was a strong positive correlation between endotoxin activity levels of subgingival LPS 
extracts and their inflammatory potential measured by the production of TNF-α and IL-8 
(p<0.001) (Fig. 4(c) and 4(d)). 
 
DISCUSSION 
The distinction between periodontopathogens and oral commensals is becoming increasingly 
blurred. Periodontal diseases are caused by the action of bacteria that are also present in health 
and that involves complex host–microbe interactions [15].  An omics approach to periodontal 
diseases’ aetiopathogenesis can potentially be used to detect microbial factors responsible for 
subclinical alterations in tissue metabolism, inflammatory cell recruitment and bone 
remodelling before extensive clinical damage has occurred [16]. 
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Lipopolysaccharide is an essential microbial macromolecule found on the outer surface of 
Gram-negative bacteria, which plays a critical role in maintaining bacterial structural integrity 
and establishing selective permeability of the bacterial cell wall [17]. LPS from 
periodontopathogenic bacteria, and particularly its lipid A domain, is recognized as a foreign 
molecule by the human host and is crucial for triggering an inflammatory response in 
periodontal tissues [18]. The ability of P.gingivalis to modify the structure of its lipid A 
moieties is critical for establishing dysbiotic subgingival biofilm communities associated with 
periodontal diseases in an animal model [19].   The LPS structure and immunogenicity of other 
periodontal pathogens, T. forsythia, A. actinomycetemcomitans and F.nucleatum have been 
published but the correlations between lipid A chemical composition and the disease status and 
progression remains elusive [20] [21] [22] .  
This is the first study to examine lipid A compositions of LPS isolated directly from 
subgingival biofilm samples and not from cultured bacteria. We show here that there are 
significant structural differences between lipid A isoforms isolated from subgingival plaque 
samples from healthy individuals and patients with chronic periodontitis. MS analysis revealed 
the presence of peaks at a higher m/z ratio in CP patients that correspond to more 
phosphorylated and over-acylated lipid A isoforms. These peaks were not observed in healthy 
patients or in CP patients after periodontal treatment. There is strong evidence that the 
expression of highly phosphorylated and acylated lipid A isoforms is an important virulence 
factor of many prominent human pathogens. John et al. have shown that lipid As of all N. 
meningitis invasive isolates are hexa-acylated whereas lipid As of significant number of carrier 
strains are penta-acylated [23].  P.aeruginosa from cystic fibrosis patients is able to synthesise 
a unique hepta-acylated lipid A moiety, not normally present in environmental isolates, that 
significantly contributes to the overall inflammatory burden of the airways of these patients 
[24]. In contrast, H.pylori modifies its lipid A by removal of phosphate groups from the 1- and 
4′-positions of the lipid A backbone producing under-acylated and under-phosphorylated lipid 
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A isoforms which are characterised by strikingly low endotoxicity. These modifications 
decrease the recognition of this bacterium by TLR4 and are key to its ability to colonize a 
mammalian host [25].  
Previous studies have shown that periodontal therapy leads to a rapid reduction in periodontal 
pathogens and a slower reduction in other species that can be sustained for at least 2 years [26]. 
Our results complement these findings with the fact that not only is the composition of 
subgingival microflora different between healthy and diseased patients but also that there are 
significant differences in microbial structural components at a subspecies level. Further studies 
are needed to determine the dynamics and stability of these changes in longer terms.  
One of the limitations of our study is that the patient in the healthy group were younger than 
the periodontitis patients. The influence of ageing on the lipid A structure is not known but the 
long-term stability of the oral microbiome and the similarity of subgingival microbiota 
composition between older adults and youngsters with periodontal health and periodontitis 
have been documented [27].  
The recombinant factor C assay (rFC) is widely used for the screening of lipopolysaccharide 
in pharmaceutical products and can detect a wide range of divergent LPS structural species 
[28]. The minimal lipid A structural prerequisites for the activation of factor C is the presence 
of the 4’- phosphate-diglucosamine backbone. However, full expression of  factor C activity is 
also dependent on the presence of fatty acids attached to this backbone, and interestingly does 
not depend on the type of LPS aggregate structure [29]. The ratio of high endotoxic and low 
endotoxic LPS is crucial for the regulation of the intestinal immune balance, where high 
endotoxic LPS isoforms support intestinal inflammation while low endotoxic LPS promotes 
intestinal homeostasis [30]. Our results show significantly increased endotoxin activity of 
subgingival plaque samples from CP patients compared to healthy individuals and treated CP 
patients. The differences in endotoxin activity are in agreement with different lipid A isoforms 
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observed in these three groups of samples. Subgingival endotoxin activity levels exhibited a 
high level of sensitivity, specificity and accuracy in confirming the clinical classification of 
chronic periodontitis status.  
The destruction of alveolar bone and periodontal ligament is caused by the ability of 
subgingival microbial community to induce a dysregulated inflammatory response in 
periodontal tissues [31]. Subgingival plaque samples from diseased sites have been shown to 
strongly activate TLR4, whereas matched samples obtained from healthy sites have been more 
variable with some of them displaying strong TLR4 antagonism [12]. In our study, 
inflammatory potential of subgingival LPS extracts, measured by the production of TNF-α and 
IL-8 in THP-1 differentiated macrophages, was significantly higher in diseased patients 
compared to healthy individuals for TNF-α, and between diseased and both healthy and post-
treatment samples for IL-8.  In addition, a strong, positive correlation between subgingival 
endotoxin activity levels and inflammatory potentials of subgingival LPS extracts supports a 
potential use of subgingival endotoxin activity measurements as a biomarker for the 
development of inflammatory periodontal conditions.  
This is the first study to consider structure-function-clinical implications of different lipid A 
isoforms present in the subgingival niche and sheds new light on molecular pathogenic 
mechanisms of subgingival biofilm communities. The results of this study may influence the 
development of a novel, lipid A based, chair-side test for personalised, point-of-care decision 
making and new approaches to the treatment of periodontal diseases by manipulating bacterial 
ability to modify their LPS. Further studies are needed to confirm the presence of lipid A 
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TABLES:   
Table 1: Summary of clinical characteristics of the study population (means ± SD). 
 Healthy n=33                      Periodontitis n=32 
           Baseline     Post-treatment 
Age (years) 31 ± 9 46 ± 9 46 ± 9 
O’Leary Plaque 
Index (%) 
14.68 ± 5.02 56.65 ± 21.53 33.92 ± 14.20 
Bleeding Index (%) 2.22 ± 2.76 41.47 ± 18.49 23.06 ± 13.31 
Probing Depth 
(mm) 


















Fig. 1 Illustrative electrospray ionisation mass spectra of lipid A isolated from a) P.gingivalis 
LPS (InvivoGen); and pooled subgingival plaque samples obtained from b) healthy 
individuals; c) chronic periodontitis patients; and d) chronic periodontitis patients three months 




Fig. 2 Endotoxin activity of subgingival LPS extracts from individuals with healthy 
periodontium and chronic periodontitis patients before and after periodontal treatment. Lines 
represent mean values with SEM. (*** p<0.001; ** p<0.01). 
 
 
Fig. 3 The ROC curve for endotoxin activity (EU) in healthy and diseased patients as a 
biomarker for the disease status.   
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Fig. 4  The production of TNF-α (a) and IL-8 (b) by macrophages challenged with LPS extracts 
from healthy, diseased and post-treatment subgingival plaque samples for 18 hours. The 
correlation between TNF-α (c) and IL-8 levels (d) and subgingival endotoxin activity. (* 
p<0.05; *** p<0.001). 
 
